{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T21:06:15Z","timestamp":1788815175646,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Allergology International"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.alit.2025.09.004","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:28:05Z","timestamp":1760538485000},"page":"200-206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["The Cyto-LTT: A multiplex cytokine assay to detect and assess the strength of T cell reactivity in drug hypersensitivity"],"prefix":"10.1016","volume":"75","author":[{"given":"Tim","family":"Peyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9381-5943","authenticated-orcid":false,"given":"Lester","family":"Thoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Yerly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Hausmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Joerg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8117-359X","authenticated-orcid":false,"given":"Werner J.","family":"Pichler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.alit.2025.09.004_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2021.113036","article-title":"Lymphocyte transformation test: history and current approaches","volume":"493","author":"Sachs","year":"2021","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.alit.2025.09.004_bib2","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/j.1398-9995.2004.00547.x","article-title":"The lymphocyte transformation test in the diagnosis of drug hypersensitivity","volume":"59","author":"Pichler","year":"2004","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2025.09.004_bib3","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1034\/j.1398-9995.2001.000115.x","article-title":"In vitro T-cell responses to \u03b2-lactam drugs in immediate and nonimmediate allergic reactions","volume":"56","author":"Luque","year":"2001","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2025.09.004_bib4","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1111\/j.1398-9995.2007.01553.x","article-title":"Utility of the lymphocyte transformation test in the diagnosis of drug sensitivity: dependence on its timing and the type of drug eruption","volume":"62","author":"Kano","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2025.09.004_bib5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1398-9995.2007.01516.x","article-title":"CD69 upregulation on T cells as an in vitro marker for delayed-type drug hypersensitivity","volume":"63","author":"Beeler","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2025.09.004_bib6","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1046\/j.1365-2222.2002.01382.x","article-title":"Determination of interleukin-5 secretion from drug-specific activated ex vivo peripheral blood mononuclear cells as a test system for the in vitro detection of drug sensitization","volume":"32","author":"Sachs","year":"2002","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.alit.2025.09.004_bib7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1398-9995.2009.02143.x","article-title":"In vitro detection and characterization of drug hypersensitivity using flow cytometry","volume":"65","author":"Martin","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2025.09.004_bib8","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jdermsci.2017.03.007","article-title":"Novel interferon-\u03b3 enzyme-linked immunoSpot assay using activated cells for identifying hypersensitivity-inducing drug culprits","volume":"86","author":"Kato","year":"2017","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.alit.2025.09.004_bib9","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.jaip.2017.09.004","article-title":"The combined utility of Ex vivo IFN-\u03b3 release enzyme-linked ImmunoSpot assay and in vivo skin testing in patients with antibiotic-associated severe cutaneous adverse reactions","volume":"6","author":"Trubiano","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.alit.2025.09.004_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2024.101002","article-title":"Exploring cytokine outputs for ex vivo diagnostics in drug reaction with eosinophilia and systemic symptoms (DRESS)","volume":"17","author":"Copaescu","year":"2024","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.alit.2025.09.004_bib11","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.jid.2020.11.027","article-title":"Granulysin-based lymphocyte activation test for evaluating drug causality in antiepileptics-induced severe cutaneous adverse reactions","volume":"141","author":"Chu","year":"2021","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.alit.2025.09.004_bib12","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.jaip.2020.09.048","article-title":"Detecting lesional granulysin levels for rapid diagnosis of cytotoxic T lymphocyte-mediated bullous skin disorders","volume":"9","author":"Chen","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.alit.2025.09.004_bib13","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/j.1398-9995.2009.01985.x","article-title":"Drug-specific in vitro release of IL-2, IL-5, IL-13 and IFN-\u03b3 in patients with delayed-type drug hypersensitivity","volume":"64","author":"Lochmatter","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2025.09.004_bib14","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1398-9995.2009.02180.x","article-title":"In vitro detection of cytotoxic T and NK cells in peripheral blood of patients with various drug-induced skin diseases","volume":"65","author":"Zawodniak","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2025.09.004_bib15","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jaci.2018.10.030","article-title":"Controversies in drug allergy: testing for delayed reactions","volume":"143","author":"Phillips","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2025.09.004_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2021.100602","article-title":"75 % negative skin test results in patients with suspected hypersensitivity to beta-lactam antibiotics : influencing factors and interpretation of test results","volume":"14","author":"Joerg","year":"2021","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.alit.2025.09.004_bib17","article-title":"High Cytokine Responses and Altered T Cell Activation in DRESS Patients at Risk for Multiple Drug Hypersensitivity","author":"Thoo","year":"2024","journal-title":"Authorea"},{"key":"10.1016\/j.alit.2025.09.004_bib18","first-page":"282","article-title":"SJS\/TEN: allergologische Abkl\u00e4rung sinnvoll und sicher","volume":"24","author":"Hausmann","year":"2024","journal-title":"Swiss Med Forum"},{"key":"10.1016\/j.alit.2025.09.004_bib19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.alit.2024.08.006","article-title":"Delayed drug hypersensitivity reactions: how p-i transforms pharmacology into immunology","volume":"74","author":"Pichler","year":"2025","journal-title":"Allergol Int"},{"key":"10.1016\/j.alit.2025.09.004_bib20","doi-asserted-by":"crossref","DOI":"10.1186\/cc11441","article-title":"Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics","volume":"16","author":"Schulz","year":"2012","journal-title":"Crit Care"},{"key":"10.1016\/j.alit.2025.09.004_bib21","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1398-9995.2011.02720.x","article-title":"Multiple drug hypersensitivity: Normal treg cell function but enhanced in vivo activation of drug-specific T cells","volume":"67","author":"Daubner","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2025.09.004_bib22","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000312632","article-title":"Cross-reactivity in drug hypersensitivity reactions to sulfasalazine and sulfamethoxazole","volume":"153","author":"Zawodniak","year":"2010","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.alit.2025.09.004_bib23","series-title":"Textbook of Adverse Drug Reactions","article-title":"Pathogenesis of adverse drug reactions","author":"Rawlins","year":"1977"},{"key":"10.1016\/j.alit.2025.09.004_bib24","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/bcp.12706","article-title":"The law of mass action and the pharmacological concentration-effect curve: resolving the paradox of apparently non-dose-related adverse drug reactions","volume":"81","author":"Aronson","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.alit.2025.09.004_bib25","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/bcp.12749","article-title":"Classifying ADRs - does dose matter?","volume":"81","author":"Phillips","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.alit.2025.09.004_bib26","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/cea.14423","article-title":"Glycolysis: an early marker for vancomycin-specific T-cell activation","volume":"54","author":"Gardner","year":"2024","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.alit.2025.09.004_bib27","first-page":"175","article-title":"Undressing DReSS as p-i mediated disease.","volume":"75","author":"Pichler","year":"2026","journal-title":"Allergol Int"},{"key":"10.1016\/j.alit.2025.09.004_bib28","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-044500","article-title":"Prediction of COVID-19 severity using laboratory findings on admission: informative values, thresholds, ML model performance","volume":"11","author":"Statsenko","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.alit.2025.09.004_bib29","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000458725","article-title":"Multiple drug hypersensitivity","volume":"172","author":"Pichler","year":"2017","journal-title":"Int Arch Allergy Immunol"}],"container-title":["Allergology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893025001108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893025001108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T16:44:54Z","timestamp":1774543494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1323893025001108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1323893025001108"],"URL":"https:\/\/doi.org\/10.1016\/j.alit.2025.09.004","relation":{},"ISSN":["1323-8930"],"issn-type":[{"value":"1323-8930","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Cyto-LTT: A multiplex cytokine assay to detect and assess the strength of T cell reactivity in drug hypersensitivity","name":"articletitle","label":"Article Title"},{"value":"Allergology International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.alit.2025.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Japanese Society of Allergology. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}